Ipca Laboratories has acquired Pisgah Labs, which is a US based pharmaceutical company for USD 9.65 million free of debt.
The company in a filing stated, “.. announce the acquisition of 100% share capital of Pisgah Labs Inc, a North Carolina Corporation, USA by subsidiaries Ipca Pharmaceutical Inc, USA and Onyx Scientific, UK.”
Furthermore Ipca stated, “Onyx and Pisgah’s capabilities in chemistry services will dovetail effectively with company’s capabilities in supporting Phase II to commercial scale programmes and also enable the company to manufacture small volume APIs for US market.”
